This white paper describes the impact of illness on employee productivity and the value of a health and productivity focus for the pharmaceutical industry. In addition, it explores why employers are increasingly investing in health and productivity management, and highlights the Thomson Reuters MarketScan Health and Productivity Management Database as a substantial data resource for conducting studies on the direct and indirect cost of illness and disease. Examples of published research based on MarketScan Health and Productivity Management data are included.
To receive this white paper, please complete the information requested below.